Suppliers / Weihai Disu Pharmaceutical

Weihai Disu Pharmaceutical

China 16 employees Updated 9 July 2026

Weihai Disu Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file across a filed portfolio of 2 molecules.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Alogliptin SFDA (Saudi Arabia) 1
Solifenacin Succinate US FDA 1

Also appears on these molecule pages

Alogliptin API Solifenacin API

Questions about Weihai Disu Pharmaceutical

Does Weihai Disu Pharmaceutical hold a US DMF or a CEP?
Weihai Disu Pharmaceutical holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Weihai Disu Pharmaceutical make?
2 molecules are on record against Weihai Disu Pharmaceutical, including Alogliptin and Solifenacin Succinate. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Weihai Disu Pharmaceutical?

Ask Fred what the record holds on Weihai Disu Pharmaceutical, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Comparable suppliers

MSN Laboratories shares 1 molecule Alivus Life Sciences shares 1 molecule Alembic Pharmaceuticals shares 1 molecule Honour Lab shares 1 molecule Alp Pharm Beijing shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability